ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Byrd Seeks Federal Tar-Nicotine Limit

October 22, 1976

Clinical Research Program Announcement

February 13, 1981

Komen, Baylr, UT Southwestern Form Alliance

November 13, 1987

NCI Contract Awards.

February 18, 2000

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

Fox Chase Joins Plan For Free Cancer Screening

May 9, 1986